World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
751 Aprea Therapeutics, Inc. $6.0 M United States US Healthcare US Biotechnology
752 Adaptimmune Therapeutics plc $5.9 M United Kingdom UK Healthcare UK Biotechnology
753 Titan Pharmaceuticals, Inc. $5.9 M

(July 1, 2025)

 United States US Healthcare US Biotechnology
754 Lyra Therapeutics, Inc. $5.6 M United States US Healthcare US Biotechnology
755 AVROBIO, Inc. $5.2 M

(July 1, 2024)

 United States US Healthcare US Biotechnology
756 Mawson Infrastructure Group, Inc. $5.2 M Australia Australian Healthcare Australian Biotechnology
757 Cyclerion Therapeutics, Inc. $5.1 M United States US Healthcare US Biotechnology
758 180 Life Sciences Corp. $5.0 M

(July 1, 2025)

 United States US Healthcare US Biotechnology
759 Xenetic Biosciences, Inc. $4.9 M United States US Healthcare US Biotechnology
760 Nabriva Therapeutics plc $4.5 M

(Oct. 1, 2023)

 Ireland Irish Healthcare Irish Biotechnology
761 Galmed Pharmaceuticals Ltd. $4.5 M Israel Israeli Healthcare Israeli Biotechnology
762 Enveric Biosciences, Inc. $3.8 M Canada Canadian Healthcare Canadian Biotechnology
763 ValiRx plc $3.6 M United Kingdom UK Healthcare UK Biotechnology
764 NanoString Technologies, Inc. $3.4 M

(May 1, 2025)

 United States US Healthcare US Biotechnology
765 Vallon Pharmaceuticals, Inc. $3.3 M United States US Healthcare US Biotechnology
766 Oncorus, Inc. $3.3 M

(Dec. 1, 2023)

 United States US Healthcare US Biotechnology
767 Virios Therapeutics, LLC $3.2 M United States US Healthcare US Biotechnology
768 CNS Pharmaceuticals, Inc. $3.0 M United States US Healthcare US Biotechnology
769 Vaccinex, Inc. $3.0 M United States US Healthcare US Biotechnology
770 Affimed N.V. $3.0 M

(July 1, 2025)

 Germany German Healthcare German Biotechnology
771 Artelo Biosciences, Inc. $2.6 M United States US Healthcare US Biotechnology
772 Gamida Cell Ltd. $2.5 M

(May 1, 2025)

 Israel Israeli Healthcare Israeli Biotechnology
773 InVivo Therapeutics Holdings Corp. $2.4 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
774 Universe Pharmaceuticals, Inc. $2.3 M China Chinese Healthcare Chinese Biotechnology
775 Avenue Therapeutics, Inc. $2.2 M United States US Healthcare US Biotechnology
776 Portage Biotech, Inc. $1.7 M Virgin Islands (British) Virgin Islands (British) Healthcare Virgin Islands (British) Biotechnology
777 Sorrento Therapeutics, Inc. $1.7 M United States US Healthcare US Biotechnology
778 Galera Therapeutics, Inc. $1.7 M United States US Healthcare US Biotechnology
779 ADiTx Therapeutics, Inc. $1.6 M United States US Healthcare US Biotechnology
780 Enzolytics, Inc. $1.4 M United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2026

751. Aprea Therapeutics, Inc.

Company Profile: Aprea Therapeutics, Inc.
Market Cap (USD): $6.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

752. Adaptimmune Therapeutics plc

Company Profile: Adaptimmune Therapeutics plc
Market Cap (USD): $5.9 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

753. Titan Pharmaceuticals, Inc.

Company Profile: Titan Pharmaceuticals, Inc.
Market Cap (USD): $5.9 M (July 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

754. Lyra Therapeutics, Inc.

Company Profile: Lyra Therapeutics, Inc.
Market Cap (USD): $5.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

755. AVROBIO, Inc.

Company Profile: AVROBIO, Inc.
Market Cap (USD): $5.2 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

756. Mawson Infrastructure Group, Inc.

Company Profile: Mawson Infrastructure Group, Inc.
Market Cap (USD): $5.2 M
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

757. Cyclerion Therapeutics, Inc.

Company Profile: Cyclerion Therapeutics, Inc.
Market Cap (USD): $5.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

758. 180 Life Sciences Corp.

Company Profile: 180 Life Sciences Corp.
Market Cap (USD): $5.0 M (July 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

759. Xenetic Biosciences, Inc.

Company Profile: Xenetic Biosciences, Inc.
Market Cap (USD): $4.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

760. Nabriva Therapeutics plc

Company Profile: Nabriva Therapeutics plc
Market Cap (USD): $4.5 M (Oct. 1, 2023)
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Biotechnology

761. Galmed Pharmaceuticals Ltd.

Company Profile: Galmed Pharmaceuticals Ltd.
Market Cap (USD): $4.5 M
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

762. Enveric Biosciences, Inc.

Company Profile: Enveric Biosciences, Inc.
Market Cap (USD): $3.8 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

763. ValiRx plc

Company Profile: ValiRx plc
Market Cap (USD): $3.6 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

764. NanoString Technologies, Inc.

Company Profile: NanoString Technologies, Inc.
Market Cap (USD): $3.4 M (May 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

765. Vallon Pharmaceuticals, Inc.

Company Profile: Vallon Pharmaceuticals, Inc.
Market Cap (USD): $3.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

766. Oncorus, Inc.

Company Profile: Oncorus, Inc.
Market Cap (USD): $3.3 M (Dec. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

767. Virios Therapeutics, LLC

Company Profile: Virios Therapeutics, LLC
Market Cap (USD): $3.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

768. CNS Pharmaceuticals, Inc.

Company Profile: CNS Pharmaceuticals, Inc.
Market Cap (USD): $3.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

769. Vaccinex, Inc.

Company Profile: Vaccinex, Inc.
Market Cap (USD): $3.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

770. Affimed N.V.

Company Profile: Affimed N.V.
Market Cap (USD): $3.0 M (July 1, 2025)
Country: Germany
Sector: German Healthcare
Industry: German Biotechnology

771. Artelo Biosciences, Inc.

Company Profile: Artelo Biosciences, Inc.
Market Cap (USD): $2.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

772. Gamida Cell Ltd.

Company Profile: Gamida Cell Ltd.
Market Cap (USD): $2.5 M (May 1, 2025)
Country: Israel
Sector: Israeli Healthcare
Industry: Israeli Biotechnology

773. InVivo Therapeutics Holdings Corp.

Company Profile: InVivo Therapeutics Holdings Corp.
Market Cap (USD): $2.4 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

774. Universe Pharmaceuticals, Inc.

Company Profile: Universe Pharmaceuticals, Inc.
Market Cap (USD): $2.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

775. Avenue Therapeutics, Inc.

Company Profile: Avenue Therapeutics, Inc.
Market Cap (USD): $2.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

776. Portage Biotech, Inc.

Company Profile: Portage Biotech, Inc.
Market Cap (USD): $1.7 M
Country: Virgin Islands (British)
Sector: Virgin Islands (British) Healthcare
Industry: Virgin Islands (British) Biotechnology

777. Sorrento Therapeutics, Inc.

Company Profile: Sorrento Therapeutics, Inc.
Market Cap (USD): $1.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

778. Galera Therapeutics, Inc.

Company Profile: Galera Therapeutics, Inc.
Market Cap (USD): $1.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

779. ADiTx Therapeutics, Inc.

Company Profile: ADiTx Therapeutics, Inc.
Market Cap (USD): $1.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

780. Enzolytics, Inc.

Company Profile: Enzolytics, Inc.
Market Cap (USD): $1.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Stay in touch